Ajouter à la (aux) collection (s) Ajouter à enregistré
  1. Sciences
  2. Médecine
  3. Cancérologie

Combined targeting of EGFR/HER promotes anti-tumor efficacy

publicité
publicité
Documents connexes
EGFR in Non-Small Cell Lung Cancer Introduction Methodology
EGFR in Non-Small Cell Lung Cancer Introduction Methodology
MSI test - Oncomip
MSI test - Oncomip
Role Of Epithelial–To–Mesenchymal Transition In Acquired Drug
Role Of Epithelial–To–Mesenchymal Transition In Acquired Drug
THERAPIES CIBLEES : INDICATIONS ET TOXICITES
THERAPIES CIBLEES : INDICATIONS ET TOXICITES
Lung Cancer Combined inhibition
Lung Cancer Combined inhibition
000912103.pdf (1.004Mb)
000912103.pdf (1.004Mb)
Molecular modeling and description of a newly
Molecular modeling and description of a newly
NEWS & VIEWS Afatinib—new therapy option for EGFR-mutant lung cancer
NEWS & VIEWS Afatinib—new therapy option for EGFR-mutant lung cancer
Author Manuscript Published OnlineFirst on December 26, 2013; DOI: 10.1158/0008-5472.CAN-13-1750
Author Manuscript Published OnlineFirst on December 26, 2013; DOI: 10.1158/0008-5472.CAN-13-1750
Alterations in epidermal growth factor receptors Open Access
Alterations in epidermal growth factor receptors Open Access
MÚdecine_personnalisÚe_-_K-RAS_Erbitux_ou_Vectibix.pptx
MÚdecine_personnalisÚe_-_K-RAS_Erbitux_ou_Vectibix.pptx
The Ribonucleoprotein Pancreatic Ductal Adenocarcinoma Cells 5HYLVHG0DQXVFULSWLQ:RUGRU57) ZLWKFKDQJHVPDUNHG
The Ribonucleoprotein Pancreatic Ductal Adenocarcinoma Cells 5HYLVHG0DQXVFULSWLQ:RUGRU57) ZLWKFKDQJHVPDUNHG
Téléchargement
publicité